Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
|
| gptkbp:administeredBy |
gptkb:physician
|
| gptkbp:alternativeTo |
allograft bone
autograft bone |
| gptkbp:approvalYear |
2015
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:contains |
beta-tricalcium phosphate (β-TCP)
recombinant human platelet-derived growth factor (rhPDGF-BB) |
| https://www.w3.org/2000/01/rdf-schema#label |
AUGMENT Bone Graft
|
| gptkbp:indication |
patients with insufficient autograft material
|
| gptkbp:manufacturer |
gptkb:Wright_Medical_Group
|
| gptkbp:marketedIn |
gptkb:Canada
gptkb:Europe gptkb:United_States |
| gptkbp:riskFactor |
infection
immune response delayed healing |
| gptkbp:routeOfAdministration |
implantation
|
| gptkbp:usedFor |
orthopedic surgery
bone repair ankle and hindfoot fusion |
| gptkbp:bfsParent |
gptkb:Wright_Medical_Group
|
| gptkbp:bfsLayer |
7
|